首页> 美国政府科技报告 >Initial Submission: Combined Oncogenicity and Toxicity Study of N-(2,4-Difluorophenyl) -2-(3-(Trifluoromethyl)Phenoy) 3-Pyridine-Carboximide in Rats with Cover Letter dated 08/13/1992
【24h】

Initial Submission: Combined Oncogenicity and Toxicity Study of N-(2,4-Difluorophenyl) -2-(3-(Trifluoromethyl)Phenoy) 3-Pyridine-Carboximide in Rats with Cover Letter dated 08/13/1992

机译:初步提交:联合致癌性和毒性研究N-(2,4-二氟苯基)-2-(3-(三氟甲基)苯基)3-吡啶 - 羧酰亚胺在大鼠的封面信函日期为1992年8月13日

获取原文

摘要

This study was submitted under Section 8(e) because of increased severity of testicular degeneration and a significant increase in the incidence of skin fibromas for the high dose males. Test material was administered to F-344 rats (50/sex/group) via admixture into the diet at concentrations of 0, 500, 2500, or 12,500 ppm for approximately 104 weeks. A dose-related effect on body weights was observed throughout the study with high dose males showing approximately a 20 to 30% depression in body weight gain. Histopathological examination revealed a statistically significant increase in the incidence of a lack of sperm in the epididymides and extramedullary hemopoiesis and hemosiderosis in the spleen for high dose males. The findings in the epididymides was not clearly associated with histopathological changes in the testes related to treatment, but the labDratOry reported treated males sacrificed at study termination had an increased severity of testicular degeneration. A significant lucrease in the incidence of skin fibromas for the high dose males was also noted. However, this Increase is well within historical control ranges of 4 to 26% for this tumor. No treatment-related microscopic lesions were observed in females.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号